Yost Joins VDF Board
Noted investment researcher joins board of directors of Vascular Disease Foundation, a national nonprofit.
Lakewood, CO (PRWEB) November 22, 2004 -- Mary L. Yost, co-founder of The
Sage Group, Atlanta, GA, has been named to the Board of Directors of the
Vascular Disease Foundation. Based in Atlanta, The Sage Group conducts
independent research offering clients a unique disease-based approach to
investing in the pharmaceutical, medical device and biotechnology
industries.
Ms. Yost is recognized as an experienced research analyst in
the health care sector. She has more than three decades’ experience on Wall
Street as a buy-side and sell-side analyst, as well as portfolio management and
venture capital investment and has worked for such firms as Montgomery
Securities, EF Hutton, Interstate Johnson Lane and Builder Investment
Group.
During her career, Ms. Yost has researched all areas of health
care products and services, including medical technology, biotechnology and
pharmaceuticals. She has been particularly successful in identifying major
trends in the health care industry and analyzing the investment impact of these
changes on specific sub-sectors and companies.
Ms. Yost is a graduate of
the University of California at Berkeley, where she received a bachelor’s degree
in Economics and Geography with distinction in general scholarship. She received
an MBA in Finance from UC Berkeley in 1970.
About the Vascular Disease
Foundation:
The Vascular Disease Foundation is a nonprofit, public
educational organization dedicated to increasing awareness of the prevention,
diagnosis and management of vascular diseases. Its outstanding board of
directors includes physicians, nurses, vascular sonographers, rehabilitation
professionals, and clinical researchers who have been on the forefront of
fighting vascular diseases for many years.
For more information on the
Vascular Disease Foundation, or about vascular diseases, call 1-866-723-4636 or
visit www.vdf.org.
# # #
Source : http://www.prweb.com/releases/2004/11/prweb180459.htm